Hims Faces Sales Challenges Amid Rising Telehealth Competition
As competition in the telehealth sector intensifies, Hims has reported a decline in sales. The company is navigating a challenging landscape, with significant developments in the biotech field.
Editorial Staff
1 min read
Updated 9 days ago
Hims has encountered difficulties in its sales performance, attributed to the increasing competition within the telehealth industry. This trend raises concerns about the company's market position.
In related news, Bristol Myers Squibb has formed a partnership with Hengrui Pharma, indicating ongoing strategic collaborations in the biotech sector.
Additionally, Viiv Healthcare recently faced a setback in a legal case concerning an HIV treatment, highlighting the challenges that companies in this field continue to confront.